Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-09-26

Clinical Trial Update: Pathophysiologic Study to Understand and Possibly Treat Nocturia [NA]

View source ↗

Summary

The clinical trial examining the pathophysiology and potential treatment for nocturia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Nocturia | NA | Status: WITHDRAWN